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Abstract 
Background 
As an important part of a pilot study to determine the feasibility of a large randomised controlled 
trial (RCT) comparing use of the Manchester Acute Coronary Syndromes (MACS) decision rule to 
standard care, we aimed to explore patient attitudes and potential barriers to participation in a trial 
of this nature.    
Methods 
We conducted a qualitative study nested within a pilot RCT comparing use of the MACS rule (which 
could enable some patients with chest pain to be discharged earlier) to standard care. Semi-
structured interviews with consenting participants were conducted with reference to a bespoke topic 
guide. Interviews were audio recorded, transcribed verbatim and analysed using the Framework 
method with an inductive approach. 
Results 
The ten interviewees expressed that participation in the trial was generally acceptable. All but one 
recommended participation to others. Participants who were in pain or anxious at the time of arrival 
reported that the initial invitation to participate in the trial was sometimes made too early. The 
approach was welcome providing they had been given time to settle. Interviewees welcomed the 
opportunity that trial participation offered for them to play a more active role in their healthcare and 
to reduce unnecessary waiting time. Participants appeared to like that participation in the trial might 
mean they could return home sooner and welcomed the provision of follow-up. Although several 
participants described being generally sceptical of medical research, they were amenable to 
participation in this trial. This appears to be because they agreed with the need for research in this 
field and perceived the intervention as non-invasive.  
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Conclusions 
Patients were positive about their participation in this RCT comparing the MACS rule to standard 
care. A number of areas for improving trial design were identified and should be considered in the 
planning of future large trials.  
 
Trial registration: ISRCTN 86818215 
Research Ethics Committee reference: 13/NW/0081 
UKCRN registration ID: 14334 
 
Abbreviations used in this manuscript 
MACS  Manchester Acute Coronary Syndromes 
ED  Emergency Department 
RCT  Randomised controlled trial 
ACS  Acute Coronary Syndromes 
ECG  Electrocardiogram 
hs-cTnT  High sensitivity cardiac troponin T 
H-FABP  Heart-type fatty acid binding protein 
 
What this study is about 
The Manchester Acute Coronary Syndromes (MACS) decision rule has been shown to risk stratify 
patients presenting with chest pain to the Emergency Department, potentially reducing unnecessary 
hospital admissions. Evaluation of the patients perspective before engaging on a full randomised 
controlled trial is essential to determine patient-perceived acceptability and identify weaknesses in 
the trial design. 
What this study adds 
Our analysis suggests that patients were positive about participation in this randomised controlled 
trial. However several areas of improvement for future large trials have been identified. 
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Background 
Conducting research in emergency settings is notoriously challenging, particularly when it involves 
evaluation of a time critical, complex intervention. Participants must rapidly digest information and 
make important decisions about their participation in the study while in the midst of a suspected 
medical emergency. Recruiting enough patients in a timely fashion is a common difficulty in clinical 
trials. Despite the difficulties relatively little remains known about the patient’s perspective.[1,2] We 
recently completed a pilot randomised controlled trial, which aimed to evaluate the feasibility of a 
definitive trial of such an intervention. 
 
The Manchester Acute Coronary Syndromes (MACS) clinical decision rule is a computer-based model 
that has been shown to identify patients presenting to the Emergency Department (ED) with 
suspected acute coronary syndromes (ACS), who could safely be discharged following a single blood 
test.[3,4]  
As an important component of a pilot study designed to evaluate the feasibility of a randomised 
controlled trial (RCT) comparing use of the MACS rule to standard care, we conducted a qualitative 
study aiming to explore the acceptability of participation in this trial from a patient’s perspective to 
primarily guide improvement of the trial design. Secondarily, this qualitative study aimed to explore 
patient experiences in a RCT of this nature in the emergency setting in general.  
 
Methods 
This qualitative study was nested in a pilot randomised controlled trial comparing use of the MACS 
decision rule to standard care. We included consenting adults aged ≥ 18 years presenting with 
suspected ACS to one of the two participating trial centres (Manchester Royal Infirmary). This study 
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was approved by the Greater Manchester Central Research Ethics Committee (reference 
13/NW/0081).  
 
The trial intervention had to be completed within 4 hours of arriving in the ED, so patients were 
approached on arrival and asked to give initial verbal consent to participate in the trial by either a 
research nurse during office hours or a GCP-trained physician.  They were then provided with a 
patient information sheet and given time to further consider participation before consenting in 
writing.  Those who provided written informed consent were then randomly allocated to either the 
control group (which received standard care according to contemporary guidelines) or the 
intervention group (which received care guided by the MACS decision rule and who may therefore 
have been identified as eligible for immediate discharge following a single blood test). Participants 
were followed up by telephone for the primary outcome (successful discharge within 4 hours of 
arrival without an incident major adverse cardiac event) after 30 days. Patients eligible for early 
discharge in the MACS pilot trial were asked to return for a follow-up blood test they otherwise 
would have had during their hospital admission. This element of the trial design had been suggested 
as an extra safeguard by a service user group, which we consulted in the design phase. 
 
A total of 283 patients had been screened initially with 145 not meeting inclusion criteria and seven 
(2.5%) declining consent. There were 131 patients included in the MACS pilot trial with a mean age of 
58.9 years (SD 16.3). Participants were 40% female and a majority of 66% had White British ethnic 
origin, followed by 9% Asian Pakistani. Of the patients in the intervention arm 16 (24%) were eligible 
for early discharge according to the MACS rule. All 131 patients who participated in the pilot trial 
were also asked to provide written informed consent to participate in this qualitative study. We 
aimed to purposively sample consenting participants to maximise heterogeneity (according to age, 
Page 7 of 23 
 
sex, ethnic origin and MACS risk group).  Those participants were then offered an appointment at a 
mutually convenient time.  
 
Between 3/2014 and 5/2014, semi-structured interviews were conducted by one of two 
interviewers. Nine interviews were conducted by HA (a nephrologist who was otherwise 
independent of the trial) and one was conducted by RB (emergency physician and principal 
investigator of the MACS pilot trial). Interviews took place 3 to 6 months after initial patient 
presentation to the ED using a bespoke topic guide (see Supplementary Appendix). To maximise 
engagement, either daytime or evening interviews were available on either the telephone or in 
person at a Clinical Research Facility adjacent to the hospital. The interviews were audio recorded 
and transcribed verbatim.  
 
We analysed the data using Framework, a well described and accepted methodology suitable for 
qualitative health services research.[5] The analysis consisted of seven phases: 1) transcription, 2) 
familiarization with the data, 3) coding, 4) developing a working analytical framework, 5) applying the 
analytical framework, 6) charting data into the framework matrix, and 7) interpreting the data.[6]  
 
Interview data were analysed according the Framework Analysis methodology using NVivo V.10 (QSR 
International Pty Ltd, 2012). RB and PB independently applied an inductive approach to the thematic 
analysis deriving the initial coding.[7]  Through a process of discussion involving three authors (PB, RB 
and SK), further themes were considered until a final coding framework was agreed and applied to 
the interview data accordingly.  
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Results 
A total of 10 participants, whose baseline characteristics are summarised in Table 1, completed the 
post-trial interviews.  Two interviews were undertaken face to face (Ms. A and Ms. G) and eight by 
telephone. An overview of themes and subthemes identified from the data is shown in Table 2. 
 
NARRATIVES ABOUT MACS PILOT TRIAL PARTICIPATION AND HOSPITAL CARE 
Hospital is a safe place 
All participants except Ms. C (who commented only on her favourable impression of the staff rather 
than the trial itself) specifically described their experience of trial participation as positive overall. 
Participants seemed generally accepting of the need for hospital admission to further investigate 
their condition, feeling it was for their own good and that the hospital is a place of safety, despite the 
view that being admitted to hospital for investigations is time consuming with a lot of waiting time, 
which they tended to rate unfavourably.   
 
Convenience of care guided by the MACS rule 
Interestingly, participants gave a general sense that being treated according to the MACS rule and 
having their blood samples tested for an additional biomarker had little significance for their care, 
other than potentially allowing them to be “fast tracked” and go home earlier. Participants expressed 
trust in the clinicians that the results and recommendations would be accurate. For example, 
referring to whether she felt anxious about potentially being discharged early, Ms. A said, “Well, if 
there was a basis for [being anxious] I would have [said it]”, apparently highlighting her trust and at 
the same time her perception of having a final say. Nine of the ten participants favoured the 
opportunity to be discharged early following the results of their initial blood test. They perceived that 
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this would reduce the time they spent waiting for results, feeling out of control and taking a passive 
role.  
 
Mr. J, who was discharged early based on the MACS rule, said, “I thought it was really good. I was far 
less anxious at home knowing that I had been seen and got the reassurances that I had been given. A 
good topping and tailing inside and out and of course I was feeling very much better”. Ms. G, who 
was also discharged early, said, “It was really good, because I was quite tired by then and worn out 
and you just want to sit in your own house have a bit of sympathy, and I was able to go home and 
have a shower”. Most of those who did not get the opportunity to go home early also perceived that 
this opportunity would have been beneficial. For example, Mr. F noted that this would have helped 
to reassure his family, saying, “If I’d have got home earlier, then my family would have known that I 
was OK so that would have been a lot better”.  However, in contrast, Ms. C was more sceptical about 
research and felt “pleased to stay in hospital” as she would have felt nervous about an early 
discharge. She seemed to feel that staying in hospital overnight provided the reassurance she needed 
to confidently go home. 
 
Participants welcomed the opportunity to return for further tests as a ‘safety net’ in the trial. The 
two who had been discharged early perceived that the returning for a further blood test was 
equivalent to a very early follow up, which they welcomed and did not see as an inconvenience. The 
other participants were asked hypothetically about needing to come back for a blood test and 
showed in their responses that the time required to return in order to get the extra blood test done 
at a later date was outweighed by the benefit of being home early. A certain degree of convenience 
in pre-arranging reception processes and ideally providing patients the possibility to get the blood 
test done locally to reduce time required were mentioned as important aspects to make it as 
convenient as possible, highlighted by Ms. G stating “Actually he really made it very smooth. They did 
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a little note that I could bring with me in the evening and he had arranged for the A&E reception to 
have my details so that when I turned up I could literally just go in, have the blood test taken and go 
home so to make that quite easy.”. 
 
Preferences for engagement in care decisions 
Within this sample, participants demonstrated a wide spectrum of preferences for their level of 
involvement in decisions about their own healthcare and participation in clinical research. At one 
extreme, participants expressed a clear preference for taking a passive role. Mr. F, for example, said, 
“So, whenever medical people ask me I’ll try to go along with, you know what I mean”. 
However, others (four participants in total) expressed dissatisfaction with their passive role as a 
patient in the healthcare system, for example, remarking that they did not feel informed and 
updated while waiting for serial troponin testing. This left them feeling out of control with no 
indication on a definitive time frame to guide their wait. Ms. G, who was discharged early through 
use of the MACS rule, was later re-attended hospital and admitted for investigation. She expressed a 
strong preference for her initial experience when she was offered early discharge.  She said that the 
invitation to participate in a study gave her some feeling of control over her healthcare, which she 
desired. She said that participation in the trial was, “partly a distraction and something I could look 
and decide on”. Therefore for some, even the process of being part of the trial seemed to be 
beneficial. 
 
Research is ‘extra care’ 
All interviewees showed willingness to talk about various aspects of clinical care, which were mostly 
unrelated to trial participation. All mentioned various frustrating experiences with health services, 
including Ms. C describing a follow up outpatient appointment as “impersonal and a waste of time” 
and others commenting on administrative issues involving discharge letters not being sent timely or 
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previous medical information not being available. This seems to demonstrate that they feel 
frustrated with current health service provision. Interviewees did express that participation in the 
trial provided the benefit of getting some “extra care” including attention and better follow up due 
to participating in the trial. None of the participants reported any unexpected adverse events as a 
result of taking part in the study.  
 
FACILITATORS AND BARRIERS TO PARTICIPATION IN THE TRIAL 
Time to settle down 
Participants agreed that, once given time to settle down in the ED, they were provided with sufficient 
and clearly presented information and given the opportunity to ask for clarification about what 
participation in the MACS trial involved. They welcomed being approached to take part in the trial 
and reported being able to take an informed decision about participation eventually. They valued 
good interpersonal skills of the research staff, using words such as “friendliness”, “considerateness” 
and “competence” to describe the behaviour of research personnel who approached them. This 
seemed to generate trust and to promote participation. For instance, Ms. G described being taken 
into the “scary red Resus [Resuscitation Room]” when she first arrived, but despite this, feeling 
positive about participation from the outset, saying, “It was good because [the doctor] waited until I 
calmed down and settled in the space, which I thought was really good”.   
 
It helps others 
The participants were also motivated by a sense that the research was worthwhile. Ms. A, for 
example, decided to take part immediately, “partly because I was a scientist and partly because I 
think it is interesting, it’s the sort of thing that appeals to me”. Explaining his motivation to 
participate despite being generally sceptical of clinical research, Mr. J said, “I am very wary of these 
things because of this sort of people getting a hold of information about you and you being mithered 
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to death so I don’t sign my name or tick the box usually I don’t do it at all, but I felt that it was leading 
on to something”. 
 
Participation seemed motivated by altruism and the expectation that their participation may benefit 
both them and their families. Ms. G noted, “If people don’t take part in these things then nothing 
moves forward”. Similarly, Ms. E said, “It’s the only way to get things improved”. Ms. B remarked 
that participation “makes you feel useful” and said, “It gives satisfaction to take part in a trial”.  
 
It helps me 
However, altruism was not the sole motivation for participants, who also perceived that the research 
may bring direct personal benefits. For example, Ms. G said, “If I was picked as one of the random 
people that could do that then I would be able to go home a bit earlier and may just have to come 
back later on in the evening for a second blood test, so I thought yes, no brainer, yes please”. Indeed, 
participants seemed to value both altruism and the potential to benefit personally. For example, Mr. 
B said of his participation, “I didn’t mind as long as it helps me and anybody”. There also seemed to 
be a feeling that, by participating and potentially going home earlier, the interviewees might help to 
reduce both their own anxiety and that of family members. Mr. J said, for example, “I have got a wife 
and only one of our children lives in Manchester. But they are all down and the grandchildren are all, 
you know. It causes anxiety. Not just to yourself… When you see the anxiety in you and yours it adds 
to your anxiety”. 
 
Positive experience of research 
Nine participants said they would have recommended participation in the research to others, 
although Ms. C did not directly state an opinion. No participants expressed regret about their 
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participation and they said they felt happy to consider future participation in a related clinical trial. 
Their positive experience was sufficient to recommend participation in clinical research to others.  
 
Not ready to commit 
Participants were asked if they could perceive any potential barriers to participation in the trial.  
When asked, all but one interviewee stated clearly that they could not; but every participant did then 
go on to describe a number of factors with potential to compromise their willingness to participate. 
We have noted that participants often reported the value of having ‘time to settle down’ after arrival 
before considering participation in the trial.  Some did feel that being in pain on arrival, feeling 
overwhelmed, alone or anxious about the situation meant that they did not feel ready to commit at 
the time of the very first approach, although that unease appears to have settled soon after arrival.  
Ms. C reported that a hearing impediment affected her ability to understand the explanations 
provided about the research.   
 
Those who described being generally pain-free and comfortable at the time of arrival seemed 
pleased to be approached and were happy to participate from the outset.  However, other 
participants described feeling less welcoming of the initial approach, most often because they were 
feeling unwell, in pain or anxious. They seemed to describe feeling overwhelmed by what was 
happening.  For example, Mr. B expressed that the approach may have been made too early after his 
arrival: “At the time when I first read it I didn’t feel all that enthusiastic about it, I just wanted to find 
out what was wrong.  Whether that was just a little bit too quick that I had only just got in, but as the 
day went on and I felt a little bit better I didn’t mind”.  Ms. H seemed to feel overwhelmed by being 
asked to read the patient information sheet very soon after her arrival, saying, “When I was asked to 
read I found it terribly difficult, in those circumstances, with your mind all weary with everything that 
happened so suddenly”.    
Page 14 of 23 
 
 
Concerns about being experimented on 
Mr B. reported a dissatisfying clinical experience (apparently unrelated to the trial) of Mr. B having a 
“learner” trying to take his blood with several failed attempts, causing concerns about the overall 
clinical competence and a feeling that he had been experimented on. However, participants 
perceived the intervention (use of a decision rule) as more acceptable because it was non-invasive 
(unlike a drug trial, for example). Some interviewees described being generally sceptical of clinical 
research and initially felt anxious about participation. For example, Ms. C seemed to associate 
medical research with high profile news stories about unethical conduct, saying, “I probably wasn’t 
very cooperative.  Because you really only think about the Liverpool Pathway,* things like that.  You 
know you get stupid things in your brain”.  However, even research sceptics had decided to 
participate, which seems to have been because they perceived the intervention to be relatively non-
invasive. Ms. C went on to suggest that this reassured her about participating in this trial, saying, 
“They weren’t putting anything into my body. They were only taking my blood”. 
 
Time consuming and privacy issues 
Ms. A speculated that some people might perceive research as time consuming. Perhaps as a result 
of a misunderstanding, Ms. A believed that participation in the research caused her to stay longer in 
hospital, saying, “I think because they might have done an extra test I think I had to wait longer”. 
Others noted that some people may be concerned about their privacy. For example, Ms. C said, “I 
think there are probably people in general who would think [of] research and [be] suspicious, … 
wondering what [they] are going to do with my details”.  
 
* Liverpool Care Pathway for the Dying Patient 
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Discussion 
In this study we explored patient attitudes and perceived barriers to participation in a RCT comparing 
the use of an early rule out strategy for ACS to usual care.  Participants generally felt positive about 
trial participation, indicating good overall patient-perceived acceptability. All but one participant 
would have recommended trial participation to others and would consider future participation in 
research themselves.  
 
Despite this general positive feeling, we did identify several areas for improvement with future trial 
design.  We identified that participants who are in pain, anxious or feeling overwhelmed may feel 
overburdened if approached about trial participation soon after their arrival in the ED.  In this pilot 
study, participants were asked to provide verbal consent before any trial procedures were 
undertaken.  Because of the time critical nature of the intervention, this meant that participants 
were generally approached while their initial care (including first clinical assessment and the 
provision of treatment such as analgesia) was ongoing. Based on the unease of participants in this 
study, it may be preferable to waive verbal consent for initial trial procedures that do not affect the 
participant (such as the analysis of blood samples drawn during routine care), and waiting until the 
patient’s condition is more settled and they can provide appropriate written informed consent.    
Indeed, this approach has been taken in an ongoing cohort study by our group.  
 
Even under ideal circumstances comprehension of randomisation and clinical trial as concepts and 
making sense of those concepts, represent a serious challenge to many patients.[8,9] Therefore, it 
can be expected that this critical aspect might be even more difficult to address in an emergency 
setting clinical trial with the associated timing restraints. In the AHEAD study the problem of 
informed consent as barriers to recruitment in emergency medicine research has been discussed 
with a likewise conclusion. They furthermore pointed out that the patient viewpoint can be 
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influenced by the image portrayed of medical research in the media, which we have noted in some 
comments including one on the Liverpool Care Pathway.[10] 
 
Our findings do suggest that, in order to maximise the chance of success, future work needs to cater 
for a wide spectrum of perspectives. For example, while most participants in this study valued the 
opportunity to take an active role in decisions about their healthcare, some preferred to take a more 
passive role and to follow the advice of doctors. Similarly, although the majority of participants 
welcomed the opportunity to return home earlier as a result of the new diagnostic technology (the 
MACS rule), this feeling was not universal. One participant stated a strong preference for remaining 
in hospital, where she felt safe. This suggests that an avenue for future work may be to explore 
shared decision making. With this approach, all perspectives may be catered for. Previous research in 
this field has shown that patients who are given the opportunity to engage in shared decision making 
have greater knowledge, play a more active role in their own healthcare and more often choose to 
terminate further investigation and return home.[11]  
 
Recent findings of a qualitative study investigating the patients’ viewpoint on participation in a 
hypothetical clinical trials in an emergency setting has identified largely comparable themes like trust 
in medical professionals, concerns about personal wellbeing, motivation being driven by altruism, 
fear for personal autonomy or misunderstanding of the trial concepts.[1] So despite the specific 
context of the pilot MACS trial, the themes identified seemed more generally applicable than 
originally anticipated. 
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STRENGTH AND LIMITATIONS 
Qualitative methods have proven potential to guide optimisation of trial processes.  O’Cathain et al 
evaluated the impact of 296 qualitative studies on various clinical trials, concluding that qualitative 
methods ought to be employed at the feasibility stage, which is in support of our approach.[12]  
Although our initial emersion and coding were influenced by the topic guide used in the interview 
process we allowed for the emergence of alternative themes whenever they demonstrated an 
association with the feasibility of the MACS rule in clinical practice.  While the derivation of codes 
and the thematic framework is sometimes critiqued for being subjective and prone to introducing 
bias[13,14], we addressed this by having two independent investigators analyse the interview data to 
account for the effect of the researcher. Complementing and contrasting views generated discussion 
between the two researchers involved in the analysis with additional reference to a third, 
independent researcher (SK) to help ensure that our analysis was a valid reflection of the data, which 
is a strength of this study. 
 
Our sample size was limited by two key factors: (a) the availability of consenting participants to take 
part in interviews; and (b) the time that elapsed from participation to scheduling the interview.  We 
noted in the interview process that the time lag between participation and the actual interview 
caused some problems with recalling the events and information provided at the time of the trial in a 
number of participants warranting some caution interpreting their statements. However at the time 
of providing informed consent all participants demonstrated sufficient understanding in order to 
qualify for participation. While comprehension of the concept might have been sufficient to provide 
consent participants might still have struggled to make sense of their identity in the trial along the 
patient to research volunteer continuum, described by Heaven et al, and the necessity for a 
randomised trial.[15]  
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An unavoidable limitation of this work is that we could only include patients who participated in the 
trial and consented to be interviewed.  We could not explore the perceptions of those who did not 
take part in the trial.  For many reasons this is a poorly studied area.[16] However, based on the 
variety of different positions participants reported we are confident that the overall transferability 
within the scope of testing the feasibility of the MACS rules is not heavily affected by the sample size.  
 
Furthermore, we noticed that the lack of interviewing experience for qualitative research by both 
interviewers might have contributed to patients demonstrating the tendency to provide off-topic 
answers not related to question asked. While this might be a limitation to the overall quality of our 
interview data, it also gave patients the opportunity to speak freely about whatever they considered 
relevant. This has likely strengthened the validity of the more general viewpoint of patients on 
participating in an emergency setting RCT. The effect of the interviewers being mainly independent 
clinicians is debateable and could potentially have kept some participants to voicing concerns. The 
fact that a small number of interviews was conducted by the principal investigator of the MACS pilot 
trial due to practical reasons, could be viewed as a potential conflict of interest and was kept to an 
absolute minimum. 
 
Another limitation to our sample of interviewed participants is its homogeneity in terms of age 
distribution and ethnic diversity, though considering the original MACS trial population, our sampling 
appears to be reasonably representative.  Nevertheless, some caution might be warranted in 
extrapolating our findings to other patient groups in the MACS trial not represented in the 
interviews. 
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Conclusion 
Patients with suspected ACS felt positively about their participation in a pilot RCT comparing the use 
of the MACS rule to standard care.  They welcomed opportunities to play an active role in their care, 
to reduce unnecessary waiting and to have the opportunity for follow up blood tests as a ‘safety net’.  
We also identified several potential limitations to the trial design, which should be considered in the 
design of future larger trials. Themes identified in this specific context demonstrated great similarity 
with known barriers to patient recruitment, especially in the emergency medicine research setting.  
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Tables 
Table 1: Baseline characteristics and identifiers of interview participants 
Participant 
Identifier 
Age Gender Ethnicity 
Allocated group at 
trial participation 
Hospital 
disposition 
A 80 Female White British Intervention group Admission 
B 80 Male White British Intervention group Admission 
C 76 Female White Irish Intervention group Admission 
D 54 Female White British Control group Admission 
E 84 Female White British Control group Admission 
F 74 Male White British Control group Admission 
G 36 Female White British Intervention group Early discharge 
H 69 Female White British Control group Admission 
I 77 Female White British Control group Admission 
J 71 Male White British Intervention group Early discharge 
 
Table 2: Summary of identified themes 
Theme Subthemes 
Narratives about MACS pilot trial 
participation and hospital care  
 
 
 
 
 
 
 
Facilitators and barriers to 
participation in the trial 
Patients welcomed the convenience of care guided by the 
MACS rule 
Participants welcomed the opportunity to return for further 
tests as a ‘safety net’ 
Patients’ preferences about their role in healthcare decisions 
varied widely 
Research is ‘extra care’ 
Additional narratives 
 
Participants welcomed being approached to take part in the 
trial once they had time to settle down 
People were motivated to participate both by altruism and 
the perception that the research may benefit them and their 
families  
Participants felt positively about trial participation and would 
recommend it to others  
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Some participants could not agree to participate until they 
felt ready 
Concerns about being experimented on 
Perceiving research as time consuming 
  
 
